Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-Diamminedichloroplatinum

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 5, 2011, Pages 4153-4157

  Lee, Jason S ^a   Rodríguez Luccioni, Héctor L ^b   Méndez, Janet ^b   Sood, Anil K ^c   Lpez Berestein, Gabriel ^c   Rinaldi, Carlos ^b   Torres Lugo, Madeline ^b  

^a University of Massachusetts   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cisplatin; Iron oxide magnetic nanoparticles; Magnetic fluid hyperthermia; Synergism

Indexed keywords

ADENOCARCINOMA CELLS; ANTICANCER DRUG; CARBOXYMETHYL DEXTRAN; CELL VIABILITY; CIS-PLATIN; CYTOTOXIC; FUNCTIONALIZED; HOT WATER; HUMAN COLON; MAGNETIC FLUID HYPERTHERMIA; MAGNETIC NANOPARTICLES; NANO SCALE; PASSIVE TRANSPORT; SYNERGISM; SYNERGISTIC EFFECT;

CYTOLOGY; IRON OXIDES; MAGNETIC FLUIDS; NANOPARTICLES; PLATINUM COMPOUNDS;

HYPERTHERMIA THERAPY;

ANTINEOPLASTIC AGENT; CISPLATIN; NANOPARTICLE;

ARTICLE; CELL STRAIN CACO 2; HUMAN; HYPERTHERMIC THERAPY; MAGNETISM;

ANTINEOPLASTIC AGENTS; CACO-2 CELLS; CISPLATIN; HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS; NANOPARTICLES;

EID: 80051591595     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.3821     Document Type: Conference Paper

References (21)

1. D. Wang and S. J. Lippard, Nat. Rev. Drug Discovery 4, 307(2005).
2. B. I. Kankia, D. W. Kupke, and L. A. Marky, J. Phys. Chem. B 105, 11402(2001).
3. D. Atallah, V. Marsaud, C. Radanyi, M. Kornprobst, R. Rouzier, D. Elias, and J. M. Renoir, Int. J. Hyperthermia 20, 405(2004).
4. E. Gabano, D. Colangelo, A. R. Ghezzi, and D. Osella, J. Inorg. Biochem. 102, 629(2008).
5. E. de Bree, P. A. Theodoropoulos, H. Rosing, J. Michalakis, J. Romanos, J. H. Beijen, and D. D. Tsiftsis, Cancer Treat Rev. 32, 471(2006).
6. R. D. Issels, Eur J. Cancer 44, 2546(2008).
7. T. S. Hauck, T. L. Jennings, T. Yatsenko, J. C. Kumaradas, and W. C. W. Chan, Adv. Mater. 20, 3832(2008).
8. N. A. Brusentsov, T. N. Brusentsova, E. Y. Filinova, N. Y. Jurchenko, D. A. Kupriyanov, Y. A. Pirogov, A. I. Dubina, M. N. Shumskikh, L. I. Shumakov, E. N. Anashkina, A. A. Shevelev, and A. A. Uchevatkin, J. Magn. Magn. Mater 311, 176(2007).
9. S. Naik and E. E. Carpenter, J. Appl. Phys. 103, 1(2008).
10. Z. Jiang, B.-A. Chen, G.-H. Xia, Q. Wu, Z. Yu, T.-Y. Hong, W. Zhang, J. Cheng, F. Gao, L.-J. Liu, X.-M. Li, and X.-M. Wang, Int. J. Nanomed. 4, 107(2009).
11. M. Babincova, V. Altanerova, C. Altaner, C. Bergemann, and P. Babinec, IEEE Trans. Nanobiosci. 7, 15(2008).
12. M. Kettering, H. Zorn, S. Bremer-Streck, H. Oehring, M. Zeisberger, C. Bergemann, R. Hergt, K.-J. Halbhuber, W. A. Kaiser, and I. Hilger, Phys. Med. Biol. 54, 5109(2009).
13. K. Cheng, S. Peng, C. Xu, and S. Sun, J. Am. Chem. Soc. 131, 10637(2009).
14. T. Ohtsubo, H. Saito, N. Tanaka, H. Matsumoto, C. Sugimoto, T. Saito, S. Hayashi, and E. Kano, Cancer Lett. 119, 47(1997).
15. M. Takemoto, M. Kuroda, M. Urano, Y. Nishimura, S. Kawasaki, H. Kato, Y. Okumura, S. Akaki, S. Kanazawa, J. Asaumi, I. Joja, and Y. Hiraki, Int. J. Hyperthermia 19, 193(2003).
16. C. Van Bree, N. A. P. Franken, F. A. M. Snel, J. Haveman, and P. J. M. Bakker, Int. J. Hyperthermia 17, 337(2001).
17. S. Lefebure, E. Bubois, V. Cabuil, S. Neveu, and R. Massart, J. Mater. Res. 13, 2975(1998).
18. R. Hernández, J. Méndez, J. Lamboy, M. Torres-Lugo, F. R. Roman, and E. Melendez, Toxicology in Vitro 24, 178(2010).
19. J. W. J. Bergs, J. Haveman, R. T. Cate, J. P. Medema, N. A. P. Franken, and C. van Bree, Oncol. Rep. 18, 219(2007).
20. R. C. Rietbroek, P. M. J. van de Vaart, J. Haveman, F. A. Blommaert, A. Geerdink, P. J. M. Bakker, and C. H. N. Veenhof, J. Cancer Res. Clin. Oncol. 123, 6(1996).
21. H. L. Rodríguez-Luccioni, M. Latorre-Eteves, J. Méndez, O. Soto, A. R. Rodríguez, C. Rinaldi, and M. Torres-Lugo, Int. J. Nanomed. (2009), accepted.